Strand Life Sciences secures Indian patent for early cancer detection platform using cfDNA analysis from a single blood ...
Company Outlines Strategy to Position OneTest™ as the First Affordable, Multi-Cancer Early Detection Blood Test for Earlier ...
A machine learning program that identified patients overdue for colorectal cancer screening helped increase screening rates ...
2don MSN
Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection
The patented platform combines genome sequencing, methylation analysis and machine learning to detect cancer and identify its ...
Colorectal cancer is associated with certain microbiomes that produce microbial signatures that can be detected by a ...
Caris Life Sciences ® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine ...
A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient's risk of hepatocellular carcinoma (HCC), the most common ...
Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...
Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...
Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results